Trial Profile
Dose-dense Paclitaxel (Genexol-PM) Once a Week in Combination With Carboplatin Every 3 Weeks for Gynecologic Cancer (Adult Solid Tumor): a Phase I Trial
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 04 Apr 2019
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin
- Indications Gynaecological cancer
- Focus Adverse reactions
- Sponsors Samyang Biopharmaceuticals Corporation
- 18 Apr 2016 New trial record